TTL
Basic information
Region (hg38): 2:112482156-112541739
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TTL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 12 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 12 | 1 | 3 |
Variants in TTL
This is a list of pathogenic ClinVar variants found in the TTL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-112482480-C-T | not specified | Uncertain significance (Apr 12, 2023) | ||
2-112485935-T-G | not specified | Uncertain significance (Feb 01, 2025) | ||
2-112494134-A-T | Benign (Dec 31, 2019) | |||
2-112494189-C-G | not specified | Uncertain significance (May 15, 2024) | ||
2-112494213-A-G | not specified | Uncertain significance (Jan 24, 2025) | ||
2-112494246-A-G | not specified | Uncertain significance (Sep 08, 2024) | ||
2-112494247-A-G | not specified | Uncertain significance (Oct 21, 2021) | ||
2-112494264-A-G | not specified | Likely benign (Feb 27, 2023) | ||
2-112494303-G-A | Benign (Dec 31, 2019) | |||
2-112494334-A-G | not specified | Uncertain significance (Jan 23, 2023) | ||
2-112494341-C-T | Benign (Apr 13, 2018) | |||
2-112501232-G-C | not specified | Uncertain significance (Jan 30, 2024) | ||
2-112501320-G-C | not specified | Uncertain significance (Mar 20, 2023) | ||
2-112501326-G-A | not specified | Uncertain significance (Nov 17, 2023) | ||
2-112501339-C-T | Benign (Sep 08, 2017) | |||
2-112503120-A-T | not specified | Uncertain significance (Mar 23, 2022) | ||
2-112503124-G-A | not specified | Uncertain significance (Nov 24, 2024) | ||
2-112528749-A-G | not specified | Uncertain significance (Jan 31, 2025) | ||
2-112528754-G-A | not specified | Uncertain significance (Mar 15, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TTL | protein_coding | protein_coding | ENST00000233336 | 7 | 59586 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.357 | 0.643 | 125737 | 0 | 11 | 125748 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.71 | 135 | 204 | 0.663 | 0.0000100 | 2466 |
Missense in Polyphen | 31 | 79.208 | 0.39137 | 912 | ||
Synonymous | -0.222 | 84 | 81.4 | 1.03 | 0.00000447 | 710 |
Loss of Function | 3.01 | 4 | 17.6 | 0.227 | 7.92e-7 | 222 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000898 | 0.0000791 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the post-translational addition of a tyrosine to the C-terminal end of detyrosinated alpha-tubulin. {ECO:0000269|PubMed:25908662}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Carboxyterminal post-translational modifications of tubulin
(Consensus)
Recessive Scores
- pRec
- 0.145
Intolerance Scores
- loftool
- 0.0843
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.35
Haploinsufficiency Scores
- pHI
- 0.221
- hipred
- Y
- hipred_score
- 0.700
- ghis
- 0.499
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.234
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ttl
- Phenotype
- cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype;
Gene ontology
- Biological process
- microtubule cytoskeleton organization;C-terminal protein-tyrosinylation;regulation of axon extension;positive regulation of mitotic cell cycle;regulation of metaphase plate congression
- Cellular component
- cell
- Molecular function
- tubulin-tyrosine ligase activity;ATP binding